Galapagos NV acquires Fidelta Ltd.

On September 1, 2010, Galapagos NV acquired Fidelta Ltd., a life science company in Croatia, from Glaxosmithkline plc.

Deal at a glance

AnnouncedSeptember 1, 2010 TypeDivestiture TargetFidelta Ltd. Buyer Galapagos NV Seller Glaxosmithkline plc SectorLife Science LocationCroatia ValueNot disclosed

Target company

Fidelta Ltd.

Croatia

Life Sciencesector

2003founded

Activestatus

View the company profile →

Buyer

Galapagos NV

Company · 13 deals on record

4th transaction in life science
2nd transaction in Croatia

13deals, all time

8in this sector

2022latest

Seller

Glaxosmithkline plc

Company · 84 deals on record

84investments

57in this sector

42exits

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

CellPoint BVSame lead buyer · Jun 2022

Abound Bio, Inc.Same lead buyer · Jun 2022

Questions about this deal

Who acquired Fidelta Ltd.?Galapagos NV acquired Fidelta Ltd. on September 1, 2010.

Who sold Fidelta Ltd.?Glaxosmithkline plc was the seller.

What type of deal was it?It was a divestiture in the life science sector in 2010.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).